Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Minnesota Board of Pharmacy seeks extended legal funding, higher spending authority and support for prescription monitoring program
Summary
The Board of Pharmacy asked the Health Finance and Policy Committee to allow remaining one-time legal funds tied to a 2020 lawsuit to be used through fiscal 2027, to increase base spending authority to preserve staffing and operations, and to add recurring funds to maintain and expand the Minnesota Prescription Monitoring Program (PMP).
Deputy Director Katrina Howard and Controlled Substance Reporting Section Director Brock Reid testified March 3 that the Minnesota Board of Pharmacy needs permission to extend previously appropriated legal funds, an increase in base spending authority and additional recurring authority for the state’s prescription monitoring infrastructure.
Nut graf: The board said it received a one-time $1.5 million general fund appropriation in fiscal 2024 to cover legal expenses from litigation over the insulin safety net program (litigation identified in testimony as Pharma v. Williams). The appropriation…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
